GYRODYNE LLC (GYRO) Stock Price, Forecast & Analysis
USA - NASDAQ:GYRO - US4038291047 - Common Stock
GYRO Key Statistics, Chart & Performance
The current stock price of GYRO is 10.0064 USD. In the past month the price increased by 3.91%. In the past year, price increased by 25.08%.
GYRO Latest News, Press Relases and Analysis
GYRO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LB | LANDBRIDGE CO LLC-A | 53.31 | 4.53B | ||
| VTMX | CORP INMOBILIARIA VESTA-ADR | N/A | 2.58B | ||
| IRS | IRSA -SP ADR | N/A | 1.22B | ||
| KW | KENNEDY-WILSON HOLDINGS INC | N/A | 1.03B | ||
| FRPH | FRP HOLDINGS INC | 69.12 | 449.08M | ||
| TCI | TRANSCONTINENTAL REALTY INV | 59.21 | 388.80M | ||
| SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 307.43M | ||
| MLP | MAUI LAND & PINEAPPLE CO | N/A | 294.92M | ||
| OZ | BELPOINTE PREP LLC | N/A | 260.63M | ||
| ARL | AMERICAN REALTY INVESTORS IN | N/A | 253.88M | ||
| SRG | SERITAGE GROWTH PROP- A | N/A | 226.97M | ||
| NEN | NEW ENGLAND REALTY ASSOC-LP | 0.51 | 198.18M |
Related stock screener links
About GYRO
Company Profile
Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. The company is headquartered in St. James, New York and currently employs 4 full-time employees. The company went IPO on 2015-09-01. The Company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York. The firm owns about a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, the Company owns about 13.8 acres inclusive of the 31,421-square-foot Cortlandt Medical Center.
Company Info
GYRODYNE LLC
1 Flowerfield Ste 24
ST. JAMES NEW YORK 11780 US
CEO: Gary J. Fitlin
Employees: 7
Phone: 16315845400
GYRODYNE LLC / GYRO FAQ
What does GYRODYNE LLC do?
Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. The company is headquartered in St. James, New York and currently employs 4 full-time employees. The company went IPO on 2015-09-01. The Company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York. The firm owns about a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, the Company owns about 13.8 acres inclusive of the 31,421-square-foot Cortlandt Medical Center.
What is the stock price of GYRODYNE LLC today?
The current stock price of GYRO is 10.0064 USD. The price increased by 4.12% in the last trading session.
What is the dividend status of GYRODYNE LLC?
GYRO does not pay a dividend.
What is the ChartMill rating of GYRODYNE LLC stock?
GYRO has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the number of employees for GYRODYNE LLC?
GYRODYNE LLC (GYRO) currently has 7 employees.
What is GYRODYNE LLC worth?
GYRODYNE LLC (GYRO) has a market capitalization of 22.01M USD. This makes GYRO a Nano Cap stock.
GYRO Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to GYRO. When comparing the yearly performance of all stocks, GYRO is one of the better performing stocks in the market, outperforming 74.56% of all stocks.
GYRO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to GYRO. GYRO may be in some trouble as it scores bad on both profitability and health.
GYRO Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.31 |